& quot; B.1.1.529 & quot; contains 32 mutations, which is about twice as many as in Delta.
The UK on Thursday, November 25, announced the suspension of flights with the Republic of South Africa, Namibia, Lesotho, Botswana, Eswatini and Zimbabwe, adding all six countries to the red list.
The Guardian reports this with reference to the British Minister of Health Sajid Javid.
It is noted that the corresponding decision in the country was made against the background of the discovery of a new strain of COVID-19 “B.1.1.529”, containing 32 mutations in adhesive protein. Javid indicated that British experts are studying the specified variant of the coronavirus.
“We need more data, but we are now taking precautions,” he said. “From tomorrow, six African countries will be added to the red list, flights will be temporarily banned, and travelers should be quarantined.”
< p> The head of the British Ministry of Health said that the new COVID strain may be more infectious than Delta, and the developed vaccines in the fight against B.1.1.529 are likely to be less effective.
В Currently, no cases of infection with this variant have been detected in the UK, but the government insists on the need for “measures to protect our progress.”
“If someone has arrived from any of these countries in the last 10 days, we ask them to take PCR tests,” Javid added.
Option “B.1.1.529” has not yet been recognized in the United Kingdom alarming, but a spokesman for the country's Health Security Administration told the publication: “This is the worst option we've ever seen.”
“B.1.1.529” contains 32 mutations, roughly double the number at the “Delta”. Now there are only 59 cases of this COVID strain in the world, in particular in South Africa, Hong Kong and Botswana.
Earlier, the director of the Institute of Genetics at the University of California, Los Angeles, Francois Ballou, suggested that this COVID strain could develop during a chronic infection in a person with a weakened immune system, possibly an untreated patient with HIV/AIDS.
According to Ravi Gupta, professor of clinical microbiology at the University of Cambridge, research in his laboratory showed that two mutations in ” B.1.1.529 “increase infectivity and decrease antibody recognition.